Status:
COMPLETED
Insulin Secretory Defects in Pima Indians at High Risk for NIDDM
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
NIDDM
Eligibility:
All Genders
18-65 years
Brief Summary
The Pima Indians have the highest reported prevalence of NIDDM of any population in the world. Within this population, it is possible to identify subgroups of individuals at a particularly high risk f...
Detailed Description
The Pima Indians have the highest reported prevalence of NIDDM of any population in the world. Within this population, it is possible to identify subgroups of individuals at a particularly high risk f...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Healthy men and women (Pimas and non-Pimas)
- At least 18 years of age
- EXCLUSION CRITERIA:
- Pregnancy and/or breastfeeding
- Positive urine drug screening test
- Inability to provide informed consent
- Medical conditions or medications that, in the investigators' judgement, would affect glucose metabolism or insulin secretion. Examples include, but are not limited to: hyper- or hypothyroidism or other endocrine disorders, cardiovascular disease by history or examination, pancreatitis, hepatitis, cirrhosis or other gastrointestinal disease, renal insufficiency, active alcoholism or other substance abuse problems.
Exclusion
Key Trial Info
Start Date :
August 19 1996
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 16 2011
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT00410800
Start Date
August 19 1996
End Date
August 16 2011
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NIDDK, Phoenix
Phoenix, Arizona, United States, 85014